Securities and Exchange Commission
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d/16 of
the Securities Exchange Act of 1934
2591 TV THE HAGUE
Aegons press release, dated April 8, 2016, is included as appendix and incorporated herein by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: April 11, 2016
/s/ J.O. van Klinken
|J.O. van Klinken|
|Executive Vice President and General Counsel|
The Hague April 11, 2016
Aegon sells majority of UK annuity portfolio to Rothesay Life
Aegon announces the sale of two thirds of its UK annuity portfolio to Rothesay Life. The transaction is consistent with the companys ambition to free up capital from non-core businesses. Under the terms of the agreement, Aegon will reinsure GBP 6 billion of liabilities to Rothesay Life, followed by a Part VII transfer. The pro forma Solvency II ratio per end-2015 for Aegons operations in the United Kingdom increases to an estimated ~155% following the reinsurance transaction and ~165% following the Part VII transfer. Aegon is exploring options to also divest the remainder of its UK annuity portfolio.
I am very pleased that we have reached an agreement with Rothesay Life, said Alex Wynaendts, CEO of Aegon. This is an important step in the process to fully divest our UK annuity portfolio, and will enable us to focus on our fast-growing platform in the UK. We are confident that this transaction is also in the best interests of our annuity customers, as Rothesay Life is an established and respected specialist provider in the UK annuity market.
Aegon has not been an active player in the UK annuity market since 2010. By selling the majority of the annuity portfolio, Aegon will be able to focus on its platform which enables workplace savers and consumers to build their savings across their working lives and then manage an income in retirement with the support of a financial adviser or directly online.
As a result of the transaction, the benefit in the Solvency II own funds from transitional measures for Aegons UK annuity portfolio will be reduced. After the completion of the transaction, Aegon intends to upstream excess capital to the holding in line with Aegons capital management policy for its units.
Following the transaction, Aegon expects annual operational free cash flows from its UK operations to be reduced by approximately GBP 35 million (EUR 43 million). The expected impact of the transaction on 2016 underlying earnings before tax is approximately GBP (20) million (EUR (25) million). The reinsurance transaction is expected to result in an IFRS loss of approximately GBP 30 million (EUR 37 million) to be reported in other charges in the second quarter of 2016.
To ensure a smooth transition for its customers, Aegon and Rothesay Life will put a migration plan in place in which the administration of the annuity portfolio will be executed by Aegon until the completion of the Part VII transfer.
|Media relations||Investor relations|
|Debora de Laaf||Willem van den Berg|
|+31 (0) 70 344 8730||+31 (0) 70 344 8405|
Aegons roots go back more than 170 years to the first half of the nineteenth century. Since then, Aegon has grown into an international company, with businesses in more than 20 countries in the Americas, Europe and Asia. Today, Aegon is one of the worlds leading financial services organizations, providing life insurance, pensions and asset management. Aegons purpose is to help people achieve a lifetime of financial security. More information: aegon.com.
The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:
|||Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom;|
|||Changes in the performance of financial markets, including emerging markets, such as with regard to:|
|||The frequency and severity of defaults by issuers in Aegons fixed income investment portfolios;|
|||The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and|
|||The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds;|
|||Changes in the performance of Aegons investment portfolio and decline in ratings of Aegons counterparties;|
|||Consequences of a potential (partial) break-up of the euro or the potential exit of the United Kingdom and/or Greece from the European Union;|
|||The frequency and severity of insured loss events;|
|||Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegons insurance products;|
|||Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations;|
|||Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;|
|||Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;|
|||Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;|
|||Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;|
|||Changes in laws and regulations, particularly those affecting Aegons operations ability to hire and retain key personnel, the products Aegon sells, and the attractiveness of certain products to its consumers;|
|||Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which Aegon operates;|
|||Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer (G-SII).|
|||Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations;|
|||Acts of God, acts of terrorism, acts of war and pandemics;|
|||Changes in the policies of central banks and/or governments;|
|||Lowering of one or more of Aegons debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegons ability to raise capital and on its liquidity and financial condition;|
|||Lowering of one or more of insurer financial strength ratings of Aegons insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of its insurance subsidiaries;|
|||The effect of the European Unions Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain;|
|||Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business;|
|||As Aegons operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegons business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;|
|||Customer responsiveness to both new products and distribution channels;|
|||Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegons products;|
|||Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, which may affect Aegons reported results and shareholders equity;|
|||The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegons ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;|
|||Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegons business; and|
|||Aegons failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving and excess capital and leverage ratio management initiatives.|
Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegons expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.